TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3310340

Group type: EXPERIMENTAL
Intervention: Corneal incision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Limbal incision
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suture division
Number of subjects: 0
Study: 29725806

Group type: EXPERIMENTAL
Intervention: PPC (polyacrylate‐polyalcohol copolymer)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dx/HA (dextranomer‐hyaluronic acid copolymer)
Number of subjects: 44
Study: 26559916

Group type: EXPERIMENTAL
Intervention: Minimally fluoroscopic approach (MFA) using EnSiteTMNavXTM navigation system
Number of subjects: 262

Group type: COMPARATOR
Intervention: Conventional fluoroscopy‐guided ablation (ConvA)
Number of subjects: 262
Study: 24888426

Group type: EXPERIMENTAL
Intervention: ECHOc guided self‐help (in addition to treatment as usual)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ECHO self‐help only (in addition to treatment as usual)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual only
Number of subjects: 0
Study: 22237062

Group type: EXPERIMENTAL
Intervention: Cow-milk products
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Fruit and berry juices
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Fresh milk products and cow milk-based infant formulas
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Fat from all milk products
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Protein from fresh milk products
Number of subjects: 232
Study: 19995493

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care shared between GPs and community pharmacists
Number of subjects: 551

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care
Number of subjects: 551
Study: 18923223

Group type: EXPERIMENTAL
Intervention: Delton, a resin-based sealant
Number of subjects: 107

Group type: COMPARATOR
Intervention: Fuji VII glass ionomer cement
Number of subjects: 107
Study: 15815776

Group type: EXPERIMENTAL
Intervention: Leukocyte-depleted blood cardioplegia (group A)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard blood cardioplegia (group B)
Number of subjects: 58
Study: 12432162

Group type: EXPERIMENTAL
Intervention: Culturally appropriate smoking cessation intervention delivered in the smoker's home by trained lay health advisors (promotores) for three months
Number of subjects: 313

Group type: COMPARATOR
Intervention: California Smoker's Helpline in Spanish
Number of subjects: 313
Study: 10533840

Group type: EXPERIMENTAL
Intervention: Noradrenergic drug (S 12024‐2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 12
Study: 8579490

Group type: EXPERIMENTAL
Intervention: Neo-adjuvant therapy with adriamycin and methotrexate
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Single transfusion of allogenic bone-marrow suspension
Number of subjects: 191
Study: 1789401

Group type: EXPERIMENTAL
Intervention: Air-cleaning device equipped with a HEPA filter (2 months)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control period (2 months without air-cleaner)
Number of subjects: 9
Study: 29500828

Group type: EXPERIMENTAL
Intervention: Imagery rescripting
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Cognitive dissonance
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control (assessment-only)
Number of subjects: 107
Study: 27130379

Group type: EXPERIMENTAL
Intervention: Chevron osteotomy
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Lindgren-Turan osteotomy
Number of subjects: 66
Study: 24708578

Group type: EXPERIMENTAL
Intervention: Antibody testing
Number of subjects: 1358

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1358

Group type: EXPERIMENTAL
Intervention: BAb titres
Number of subjects: 1358

Group type: EXPERIMENTAL
Intervention: Initial BAb-positive and NAb-positive status
Number of subjects: 1358
Study: 22190137

Group type: EXPERIMENTAL
Intervention: 15 g/day pectin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6 g/day pectin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (cellulose)
Number of subjects: 0
Study: 20211323

Group type: EXPERIMENTAL
Intervention: Intracoronary BMC therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 42
Study: 18410202

Group type: EXPERIMENTAL
Intervention: Morally elevating video
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comedy video (control)
Number of subjects: 0
Study: 17221107

Group type: EXPERIMENTAL
Intervention: Fluoxetine (F) 60 mg/day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Sibutramine (S) 15 mg/day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Metformin (M) 1,700 mg/day
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 12798268

Group type: EXPERIMENTAL
Intervention: Mental imagery of plantar flexion at 40% MVC
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mental imagery of plantar flexion at 60% MVC
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mental imagery of plantar flexion at 80% MVC
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mental imagery of plantar flexion at 100% MVC
Number of subjects: 23

Group type: COMPARATOR
Intervention: Resting control trials
Number of subjects: 23
Study: 10986547

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 to 20 mg/d
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 9001648

Group type: EXPERIMENTAL
Intervention: Taurine supplemented formula (FF + T)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Taurine non-supplemented formula (FF)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Breast-fed (BF)
Number of subjects: 3
Study: 1600598

Group type: EXPERIMENTAL
Intervention: 400 mg/m2 carboplatin plus 800 mg/m2 cyclophosphamide (level 1)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 550 mg/m2 carboplatin plus 1100 mg/m2 cyclophosphamide (level 2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High doses of carboplatin and cyclophosphamide
Number of subjects: 18
Study: 6152175

Group type: EXPERIMENTAL
Intervention: ICI 141,292 (Visacor) 50 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ICI 141,292 (Visacor) 100 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ICI 141,292 (Visacor) 200 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ICI 141,292 (Visacor) 300 mg
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 30646755

Group type: EXPERIMENTAL
Intervention: Device-supported titration
Number of subjects: 151

Group type: COMPARATOR
Intervention: Routine titration
Number of subjects: 151
Study: 30418521

Group type: EXPERIMENTAL
Intervention: WebRx (25-week/15-session web-delivered intervention)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: WebRx
Number of subjects: 61

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 61
Study: 27110817

Group type: EXPERIMENTAL
Intervention: School-based comprehensive intervention including nutrition classes for children, mothers, and teachers, and physical activity classes for children.
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group received physical activity (PA) classes only.
Number of subjects: 258
Study: 24560128

Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention (BAI)
Number of subjects: 166
Study: 23056633

Group type: EXPERIMENTAL
Intervention: Pre-labor cesarean section (CS)
Number of subjects: 78166

Group type: COMPARATOR
Intervention: Trial of labor
Number of subjects: 78166

Group type: EXPERIMENTAL
Intervention: Intrapartum cesarean section and operative vaginal delivery
Number of subjects: 78166
Study: 21070707

Group type: EXPERIMENTAL
Intervention: Double extraction approach (Group 2)
Number of subjects: 59
Study: 17629725

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 52
Study: 15754200

Group type: EXPERIMENTAL
Intervention: Traditional 5‐h course on airway management
Number of subjects: 56

Group type: COMPARATOR
Intervention: Online course with 36 h access and real-time Q&A sessions
Number of subjects: 56
Study: 12046342

Group type: EXPERIMENTAL
Intervention: Lamivudine (150 mg daily) for 48 weeks
Number of subjects: 38
Study: 9459373

Group type: EXPERIMENTAL
Intervention: Onion consumption (220 g onions/d providing 114 mg quercetin/d)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Parsley consumption (5 g dried parsley/d providing 84 mg apigenin/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8590510

Group type: EXPERIMENTAL
Intervention: 60 mA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50 mA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 40 mA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 30 mA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 20 mA
Number of subjects: 90
Study: 1977265

Group type: EXPERIMENTAL
Intervention: Fluorescence microscopy of erythrocytes
Number of subjects: 14

Group type: COMPARATOR
Intervention: Traditional solvent extraction qualitative screening test for blood porphyrins
Number of subjects: 14
Study: 192685

Group type: EXPERIMENTAL
Intervention: Tibric acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clofibric acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31746448

Group type: EXPERIMENTAL
Intervention: Sustained Release (SR) Nifedipine 20 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Immediate Release (IR) Nifedipine 20 mg
Number of subjects: 16
Study: 30870163

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal tube
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (no nasopharyngeal tube)
Number of subjects: 46
Study: 28259723

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 25203421

Group type: EXPERIMENTAL
Intervention: Creatine (20 g·d(‐1) + placebo)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate (0.3 g·kg(‐1) + placebo)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Coingestion (Creatine + Sodium Bicarbonate + placebo)
Number of subjects: 9

Group type: COMPARATOR
Intervention: All conditions
Number of subjects: 9
Study: 23361456

Group type: EXPERIMENTAL
Intervention: Metformin plus letrozole
Number of subjects: 146

Group type: COMPARATOR
Intervention: Bilateral ovarian drilling
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 146
Study: 21276585

Group type: EXPERIMENTAL
Intervention: Women with CAD
Number of subjects: 1775
Study: 19447077

Group type: EXPERIMENTAL
Intervention: Preoperative disc height < 4mm
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Preoperative disc height > 4mm
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Postoperative disc height > 5mm
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Postoperative disc height > 7mm
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Clinical outcomes (NDI)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Clinical outcomes (VAS neck pain score)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Clinical outcomes (VAS arm pain score)
Number of subjects: 166
Study: 16980156

Group type: EXPERIMENTAL
Intervention: 0.2% epidural ropivacaine
Number of subjects: 35

Group type: COMPARATOR
Intervention: 1% epidural ropivacaine
Number of subjects: 35
Study: 14651356

Group type: EXPERIMENTAL
Intervention: [11C]raclopride (D2 antagonist)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 10
Study: 10588490

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser treatment (20 pps, 150 mJ) only
Number of subjects: 8

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) only
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Laser treatment first, followed by SRP 6 weeks later
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: SRP first, followed by laser therapy 6 weeks later
Number of subjects: 8
Study: 8934459

Group type: EXPERIMENTAL
Intervention: Concurrent articulatory suppression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased delay between stimulation and recall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeating 'the' continuously
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counting backwards in threes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quiet condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional tactile interference
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concurrent articulatory suppression and additional tactile interference combined
Number of subjects: 0
Study: 1679390

Group type: EXPERIMENTAL
Intervention: Cadralazine (10 mg once daily)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Prazosin (titrated from 0.5 mg to a maximum of 2 mg tds)
Number of subjects: 108
Study: 6340976

Group type: EXPERIMENTAL
Intervention: 50 mg diclofenac sodium
Number of subjects: 40

Group type: COMPARATOR
Intervention: 400 mg ibuprofen
Number of subjects: 40
Study: 30969220

Group type: EXPERIMENTAL
Intervention: Second uterine curettage
Number of subjects: 89

Group type: COMPARATOR
Intervention: No curettage (control)
Number of subjects: 89
Study: 28324753

Group type: EXPERIMENTAL
Intervention: Error augmentation feedback during training sessions
Number of subjects: 36

Group type: COMPARATOR
Intervention: Unaltered, control feedback during training sessions
Number of subjects: 36
Study: 25904425

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 33
Study: 25090255

Group type: EXPERIMENTAL
Intervention: Coparenting intervention
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Couple intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Information control group
Number of subjects: 90
Study: 22743239

Group type: EXPERIMENTAL
Intervention: UCP3 gene polymorphisms (rs1685354 and rs11235972)
Number of subjects: 1616

Group type: EXPERIMENTAL
Intervention: UCP3 gene polymorphisms (rs11235972)
Number of subjects: 1616
Study: 18670875

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 60
Study: 17899346

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15048331

Group type: EXPERIMENTAL
Intervention: Ilizarov technique in combination with minimally invasive internal fixation (group I)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional surgical procedure (group II)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Ilizarov technique (group I)
Number of subjects: 59
Study: 12566647

Group type: EXPERIMENTAL
Intervention: Percutaneous balloon valvuloplasty
Number of subjects: 80

Group type: COMPARATOR
Intervention: Open commissurotomy
Number of subjects: 80
Study: 15512286

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Methyl dopa
Number of subjects: 39
Study: 7604081

Group type: EXPERIMENTAL
Intervention: 4-Hz TENS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100-Hz TENS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no TENS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Finger temperature
Number of subjects: 24
Study: 2666737

Group type: EXPERIMENTAL
Intervention: Amphotericin B
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Donor leukocytic mass
Number of subjects: 34

Group type: COMPARATOR
Intervention: Nystatin
Number of subjects: 34
Study: 187312

Group type: EXPERIMENTAL
Intervention: Combination of 1 (2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea (CCNU), cyclophosphamide, and methotrexate
Number of subjects: 206

Group type: COMPARATOR
Intervention: Cyclophosphamide and methotrexate
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Small cell anaplastic carcinoma
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Adenocarcinoma
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Epidermoid carcinoma
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Large cell carcinoma
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Responders (small cell anaplastic carcinoma)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Responders (adenocarcinoma)
Number of subjects: 206
Study: 30122637

Group type: EXPERIMENTAL
Intervention: Mental Group Mapping
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Video 4‐Step Approach
Number of subjects: 151

Group type: COMPARATOR
Intervention: See one ‐ Do one
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control
Number of subjects: 151
Study: 25998624

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 665

Group type: COMPARATOR
Intervention: Parnaparin
Number of subjects: 665
Study: 22949107

Group type: EXPERIMENTAL
Intervention: Photohardening therapy (311 nm UVB) for 4-9 weeks
Number of subjects: 16
Study: 21866654

Group type: EXPERIMENTAL
Intervention: Unblocking the interior and purgation method (Chinese drugs infused by enteral nutrition tube)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60
Study: 19732245

Group type: EXPERIMENTAL
Intervention: Standard preventive care
Number of subjects: 235
Study: 16753439

Group type: EXPERIMENTAL
Intervention: Conveen anal plug
Number of subjects: 16
Study: 15273834

Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment for ADHD
Number of subjects: 10
Study: 11158461

Group type: EXPERIMENTAL
Intervention: Fluconazole (6 mg/kg) administered intravenously or by feeding tube every 72 hours until day of life (DOL) 7, then every 24 hours until DOL 28.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo administered for the same duration as fluconazole.
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Fluconazole (6 mg/kg)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 103
Study: 9234567

Group type: EXPERIMENTAL
Intervention: 10 mg/24 hour transdermal nitroglycerin
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 7952033

Group type: EXPERIMENTAL
Intervention: Single-dose administration of mephenytoin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose administration of dextromethorphan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose administration of caffeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of mephenytoin and dextromethorphan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of mephenytoin and caffeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of mephenytoin, dextromethorphan, and caffeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrokinetic capillary techniques
Number of subjects: 0
Study: 3281401

Group type: EXPERIMENTAL
Intervention: Early T-tube removal (postoperative day 4)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Late T-tube removal (postoperative day 7)
Number of subjects: 62
Study: 31978214

Group type: EXPERIMENTAL
Intervention: High-dose induction chemotherapy
Number of subjects: 178

Group type: COMPARATOR
Intervention: Standard induction chemotherapy
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: PBC < 1.0
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: PBC analysis
Number of subjects: 178
Study: 31170797

Group type: EXPERIMENTAL
Intervention: Improved clinical supervision and support
Number of subjects: 125

Group type: COMPARATOR
Intervention: Actual clinical supervision and support
Number of subjects: 125
Study: 28209275

Group type: EXPERIMENTAL
Intervention: Measured Resection (MR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gap Balancing (GB)
Number of subjects: 24
Study: 26201426

Group type: EXPERIMENTAL
Intervention: Pharmaceutical intervention
Number of subjects: 87
Study: 24231592

Group type: EXPERIMENTAL
Intervention: Indomethacin submicron particle capsules 40 mg 3 times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin submicron particle capsules 40 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin submicron particle capsules 20 mg 3 times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg loading dose, then 200 mg BID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20598332

Group type: EXPERIMENTAL
Intervention: Propranolol (1 mg/kg per day initially, increased to 4 mg/kg per day within 10 days)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Propranolol (4 mg/kg per day)
Number of subjects: 406
Study: 19927544

Group type: EXPERIMENTAL
Intervention: Captisol-enabled budesonide solution (CBIS), 60 microg twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional budesonide suspension (Pulmicort Respules), 250 microg twice daily
Number of subjects: 12
Study: 21255215

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15-45 mg/day)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Metformin (1000-2000 mg/day)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 110
Study: 16277094

Group type: EXPERIMENTAL
Intervention: Irinotecan and oxaliplatin combination treatment (6 cycles of oxaliplatin 85 mg/m2 on days 1 and 15, irinotecan 80 mg/m2 on days 1, 8, and 15)
Number of subjects: 34
Study: 12243600

Group type: COMPARATOR
Intervention: Acyclovir 400 mg orally 3 times daily
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg orally twice daily
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Valacyclovir 250 mg orally twice daily
Number of subjects: 151
Study: 9771641

Group type: EXPERIMENTAL
Intervention: Prelinguistic Milieu Teaching (PMT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Responsive Small Group (RSG)
Number of subjects: 58
Study: 7669537

Group type: EXPERIMENTAL
Intervention: Educational case intervention (emphasizing progressive disclosure of cases, active leadership style, and educational principles)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 18
Study: 2696232

Group type: EXPERIMENTAL
Intervention: Levothyroxine therapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: No drug (control)
Number of subjects: 74
Study: 105097

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11963821

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 105

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 105